Lerin Drug Co, Inc
Pharmacy
501 W 113th St, New York
New York, 10025-8073
212-678-0636 Lerin Drug Co, Inc is an authorized DME supplier for medicare equipments and products.
Lerin Drug Co, Inc is a Pharmacy in New York, New York. It is located at 501 W 113th St, New York and it's customer support contact number is 212-678-0636. The authorized person of Lerin Drug Co, Inc is Mr. John Peter Navarra, RPH who is President of the pharmacy and his contact number is 516-650-1870. Active license number of Lerin Drug Co, Inc is 17529 for Pharmacy in New York. Lerin Drug Co, Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Lerin Drug Co, Inc is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Lerin Drug Co, Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Lerin Drug Co, Inc |
| Type: | Pharmacy |
| Location: | 501 W 113th St, New York, New York, 10025-8073 |
| Phone: | 212-678-0636 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Mr. John Peter Navarra |
| Credentials: | RPH |
| Position: | President |
| Contact Number: | 516-650-1870 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1407847635 |
| NPI Enumeration Date: | 05 Nov, 2005 |
| NPI Last Update On: | 25 Sep, 2014 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Lerin Drug Co, Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacy | 17529 | New York | Primary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 00719044 | Medicaid | New York | |
Medicare Enrollment:
Lerin Drug Co, Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 4789702069 | O20100930023052 | Lerin Drug Co Inc | DME SUPPLIER - PHARMACY |
Products Available:
Lerin Drug Co, Inc has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | • Canes & Crutches |
| • Enteral Equipment And/or Supplies | • Enteral Nutrients |
| • Nebulizer Equipment & Supplies | • Ostomy Supplies |
| • Surgical Dressings | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 501 W 113th St, Ny, New York |
| Zip: | 10025 |
| Phone Number: | 212-749-2677 |
| Fax Number: | 212-662-3148 |
Patients can reach Lerin Drug Co, Inc at
501 W 113th St, New York, New York or can
call on customer care at 212-678-0636.
Comments/ Reviews:
Read all the reviews posted for Lerin Drug Co, Inc below. You may also share your own experience with Lerin Drug Co, Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.